Description

Caramiphen is a pharmaceutical intermediate and active ingredient with the CAS registry number 77-22-5. This compound is valued for its role in the synthesis of specific therapeutic agents, particularly in the development of antitussive and anticholinergic medications. It is a critical building block for pharmaceutical manufacturers and research institutions focused on central nervous system (CNS) and respiratory drug development.

Application

• Pharmaceutical Synthesis: Primary use as a key intermediate in the production of antitussive (cough suppressant) drugs.
• Active Pharmaceutical Ingredient (API): Serves as the core structure for certain anticholinergic and antispasmodic medications.
• Biochemical Research: Used in pharmacological studies targeting muscarinic acetylcholine receptors.
• Reference Standard: Employed as an analytical standard in quality control laboratories for method development and validation.
• Preclinical Development: Utilized in the research and development of new therapeutic agents for neurological conditions.

Basic Information

Product Name	Caramiphen
CAS No.	77-22-5
Molecular Formula	C18H27NO
Molecular Weight	273.42 g/mol
Synonyms	1-Phenylcyclopentanecarboxylic acid 2-(diethylamino)ethyl ester; Caramiphen Edisylate; Caramiphen Ethanedisulfonate; Parpanit; Panparnit; 2-Diethylaminoethyl 1-phenylcyclopentane-1-carboxylate; NSC 3795
EINECS	201-010-5

Quality Control

Our Caramiphen is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing to ensure identity, purity, and consistency, meeting the stringent requirements for pharmaceutical intermediates. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting compliance with agreed specifications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep the container tightly sealed to protect from moisture.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.